Sabinsa Notifies Alchem as to Status of Its Forskolin(ForsLean®) Patent

May 04, 2008

Sabinsa Corporation announced today that it has notified Alchem International as to the status of its patent covering the use of Forskohlin (ForsLean®), and has demanded that Alchem cease any activities that mislead the public.

Sabinsa Corporation and Sami Labs Ltd. (“Sabinsa”) co-own U.S. Patent No. 5,804,596, directed to uses of forskohlin. In order to further strengthen the ‘596 patent, Sabinsa filed a Request for Reexamination with the U.S. Patent and Trademark Office on December 1, 2004, which was ultimately granted. The case is currently on appeal to the Court of Appeals for the Federal Circuit. Pending final disposition of the case, the ‘596 patent has not been declared invalid by the PTO. Sabinsa has notified Alchem that any statements to the contrary are misleading.

Dr. Muhammed Majeed, Sabinsa CEO, said, “Sabinsa is a pioneering company that is committed to the innovation of new products. Sabinsa is able to further its commitment by protecting these innovative products through obtaining patents. Unfortunately, some companies have spread rumors about the status of our patents, leaving Sabinsa with no alternative but to take action.

Sabinsa Corporation continues to pursue all legal remedies available to protect its intellectual property, Dr. Majeed commented. “We invest significant amounts of money each year into research to develop products that can be safely and confidently used by the nutritional supplement industry,” said Dr. Majeed. “Intellectual property allows us to bring the fruits of this research to the marketplace,” he continued.

Sabinsa Corporation, which has pioneered the introduction of several Ayurvedic herbal extracts in the U.S. market, is an application oriented manufacturing and marketing company which manufactures Phytonutrients, Ayurvedic herbal extracts and specialty fine chemicals used for nutritional, pharmaceutical, cosmeceutical and food products. Sabinsa distinguishes itself by its extensive research support for its customers and products, and the scientific credentials of its key technical staff.

ForsLean® is a Registered Trademark and a product of Sabinsa Corp., and its use is addressed under U.S. Patent No. 5,804,596 and International Patents and Patents Pending.